NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release

PaxMedica (NASDAQ: PXMD), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, was featured in the latest episode of The Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Howard Weisman, CEO of PaxMedica, and Dr. Marshal Lemerani, Program Manager at the Malawi Ministry of Health, joined the program to discuss the urgent request for medical assistance from Malawi and PaxMedica’s swift response. The podcast shed light on PaxMedica’s commitment to addressing the critical shortage of medications required to combat the life-threatening sleeping sickness crisis in Malawi, with Weisman highlighting the pressing need for IV suramin (PAX-101), a crucial medication in treating Trypanosoma brucei rhodesiense Human African trypanosomiasis (“TBr HAT”), and PaxMedica’s immediate action plan to aid. Lemerani shared insights into the challenges faced by healthcare professionals in Malawi and expressed gratitude for PaxMedica’s support in this dire situation.

NOTE TO INVESTORS: The latest news and updates relating to PXMD are available in the company’s newsroom at https://nnw.fm/PXMD

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer